BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 928 filers reported holding BAXTER INTL INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $60,000 | +5.3% | 1,262 | 0.0% | 0.00% | – |
Q2 2016 | $57,000 | -3.4% | 1,262 | -11.8% | 0.00% | – |
Q1 2016 | $59,000 | -1.7% | 1,431 | -9.4% | 0.00% | -100.0% |
Q4 2015 | $60,000 | +15.4% | 1,579 | 0.0% | 0.00% | – |
Q3 2015 | $52,000 | -13.3% | 1,579 | 0.0% | 0.00% | -100.0% |
Q2 2015 | $60,000 | -47.8% | 1,579 | -6.2% | 0.00% | 0.0% |
Q1 2015 | $115,000 | -12.9% | 1,684 | -6.2% | 0.00% | 0.0% |
Q4 2014 | $132,000 | -58.6% | 1,795 | -59.6% | 0.00% | -66.7% |
Q3 2014 | $319,000 | -19.8% | 4,445 | -19.3% | 0.00% | 0.0% |
Q2 2014 | $398,000 | +135.5% | 5,505 | +139.9% | 0.00% | +50.0% |
Q1 2014 | $169,000 | -1.7% | 2,295 | -7.0% | 0.00% | 0.0% |
Q4 2013 | $172,000 | +0.6% | 2,468 | -5.1% | 0.00% | 0.0% |
Q3 2013 | $171,000 | -8.6% | 2,600 | -3.7% | 0.00% | 0.0% |
Q2 2013 | $187,000 | – | 2,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |